Literature DB >> 17968819

Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach.

Carlene A Muto1, Mary Kathleen Blank, Jane W Marsh, Emanuel N Vergis, Mary M O'Leary, Kathleen A Shutt, Anthony W Pasculle, Marian Pokrywka, Juliet G Garcia, Kathy Posey, Terri L Roberts, Brian A Potoski, Gary E Blank, Richard L Simmons, Peter Veldkamp, Lee H Harrison, David L Paterson.   

Abstract

BACKGROUND: In June 2000, the hospital-acquired Clostridium difficile (CD) infection rate in our hospital (University of Pittsburgh Medical Center-Presbyterian, Pittsburgh, PA) increased to 10.4 infections per 1000 hospital discharges (HDs); the annual rate increased from 2.7 infections per 1000 HDs to 7.2 infections per 1000 HDs and was accompanied by an increase in the frequency of severe outcomes. Forty-seven (51%) of 92 HA CD isolates in 2001 were identified as the "epidemic BI strain." A comprehensive CD infection control "bundle" was implemented to control the outbreak of CD infection.
METHODS: The CD infection control bundle consisted of education, increased and early case finding, expanded infection-control measures, development of a CD infection management team, and antimicrobial management. Process measures, antimicrobial usage, and hospital-acquired CD infection rates were analyzed, and CD isolates were typed.
RESULTS: The rates of compliance with hand hygiene and isolation were 75% and 68%, respectively. The CD management team evaluated a mean of 31 patients per month (11% were evaluated for moderate or severe disease). Use of antimicrobial therapy associated with increased CD infection risk decreased by 41% during the period 2003-2005 (P<.001). The aggregate rate of CD infection during the period 2001-2006 decreased to 4.8 infections per 1000 HDs (odds ratio, 2.2; 95% confidence interval, 1.4-3.1; P<.001) and by 2006, was 3.0 infections per 1000 HDs, a rate reduction of 71% (odds ratio, 3.5; 95% confidence interval, 2.3-5.4; P<.001). During the period 2000-2001, the proportion of severe CD cases peaked at 9.4% (37 of 393 CD infections were severe); the rate decreased to 3.1% in 2002 and further decreased to 1.0% in 2006--a 78% overall reduction (odds ratio, 20.3; 95% confidence interval, 2.8-148.2; P<.001). In 2005, 13% of CD isolates were type BI (20% were hospital acquired), which represented a significant reduction from 2001 (P<.001).
CONCLUSIONS: The outbreak of CD infection with the BI strain in our hospital was controlled after implementing a CD infection control "bundle." Early identification, coupled with appropriate control measures, reduces the rate of CD infection and the frequency of adverse events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17968819     DOI: 10.1086/522654

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  69 in total

Review 1.  Clostridium difficile in the ICU: the struggle continues.

Authors:  Linda D Bobo; Erik R Dubberke; Marin Kollef
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

2.  Is Clostridium difficile infection still a problem for hospitals?

Authors:  David A Enoch; Sani H Aliyu
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

Review 3.  Local formularies.

Authors:  D John M Reynolds; Olubunmi Fajemisin; Sara Wilds
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

Review 4.  MRSA and the environment: implications for comprehensive control measures.

Authors:  N Cimolai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-14       Impact factor: 3.267

5.  The Daniel K. Inouye College of Pharmacy Scripts: Updates on Clostridium difficile Infection: Advances in Laboratory Testing to Aid Diagnosis and Treatment.

Authors:  Louis Lteif
Journal:  Hawaii J Med Public Health       Date:  2017-02

6.  Diagnosis of Clostridium difficile infection using an UPLC-MS based metabolomics method.

Authors:  Pengcheng Zhou; Ning Zhou; Li Shao; Jianzhou Li; Sidi Liu; Xiujuan Meng; Juping Duan; Xinrui Xiong; Xun Huang; Yuhua Chen; Xuegong Fan; Yixiang Zheng; Shujuan Ma; Chunhui Li; Anhua Wu
Journal:  Metabolomics       Date:  2018-07-19       Impact factor: 4.290

7.  A cluster of fulminant Clostridium difficile colitis in an intensive care unit in Italy.

Authors:  M Guastalegname; S Grieco; S Giuliano; M Falcone; R Caccese; P Carfagna; M D'ambrosio; G Taliani; M Venditti
Journal:  Infection       Date:  2014-02-13       Impact factor: 3.553

8.  High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.

Authors:  Scott R Curry; Jane W Marsh; Kathleen A Shutt; Carlene A Muto; Mary M O'Leary; Melissa I Saul; A William Pasculle; Lee H Harrison
Journal:  Clin Infect Dis       Date:  2009-02-15       Impact factor: 9.079

9.  Interventions to Reduce the Incidence of Hospital-Onset Clostridium difficile Infection: An Agent-Based Modeling Approach to Evaluate Clinical Effectiveness in Adult Acute Care Hospitals.

Authors:  Anna K Barker; Oguzhan Alagoz; Nasia Safdar
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

10.  Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.

Authors:  Susan M Novak-Weekley; Elizabeth M Marlowe; John M Miller; Joven Cumpio; Jim H Nomura; Paula H Vance; Alice Weissfeld
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.